Manufacturing

Given the criticality of fill/finish processes, it is clear that automation is the next technological step.

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

The partnership will allow for both companies to provide end-to-end biopharmaceutical manufacturing solutions.

CordenPharma’s new starter kits are designed to enable effective formulation in the development of mRNA-based therapeutics.

This discussion explores how the management and analysis of vast data generated by advanced analytical technologies are revolutionizing the drug discovery and development process within the biopharma industry.

Webinar Date/Time: Tue, Apr 9, 2024 2:00 PM EDT

CSL will share access to Cytegrity, its proprietary stable production system for lentiviral vector production, with Genezen.

Challenges in fermentation can be addressed through equipment changes, facility design, and process development.

FDA has approved Iovance Biotherapeutics’ Amtagvi (lifileucel) for treating patients with unresectable or metastatic melanoma.

Webinar Date/Time: Thu, Mar 14, 2024 2:00 PM EDT

Webinar Date/Time: Wed, Mar 27, 2024 11:00 AM EDT

Managing the intricacies of sterile product development is imperative for successful and compliant outcomes.

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

Under the new partnership, Samsung Biologics will develop and manufacture an antibody for a LegoChem Biosciences ADC candidate.

Webinar Date/Time: Tue, Mar 5, 2024 2:00 PM EST

Webinar Date/Time: Thu, Mar 7, 2024 10:00 AM EST

Purolite and Repligen have commercially launched a new CH1 affinity resin for the purification of specialized mAbs.

Novo Holdings has entered into a merger agreement with Catalent and will acquire Catalent in a deal valued at $16.5 billion.

Webinar Date/Time: Fri, Feb 23, 2024 11:00 AM EST

The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.

Technical, regulatory, and personnel considerations characterize pharmaceutical compounding.

Effective analytics will eliminate failures, deviations, and non-conformances.

Under a new collaboration, Lonza and Oxford Nanopore aim to commercialize a CGMP-validated test for advanced analysis of mRNA products.

Given its positioning at each new year’s commencement, the J.P. Morgan Healthcare conference helps establish the tone with which the pharmaceutical industry is viewed.

The final guidance provides specific recommendations for CMC, pharmacology, toxicology, and clinical study design for CAR-T cell products.

In this exclusive Drug Digest video interview, Felicity Thomas, Europe/senior editor, Pharmaceutical Technology Group, interviews an esteemed panel of experts from IPEC Americas about excipient grades.

Webinar Date/Time: Wed, Mar 6, 2024 10:00 AM EST

Getinge has announced the inauguration of its new Global Centre of Excellence for Chemistry in the United Kingdom

The 2024 Pharmapack Europe Award winners include companies involved in ground-breaking innovations in novel drug delivery solutions, reusable connected devices, and recyclable packaging.

Under a new alliance, KBI Biopharma and Argonaut Manufacturing Services will combine their strengths to offer end-to-end biopharma development and CGMP manufacturing solutions.